CPT1A and fatty liver disease: At the molecular level, HFD-NRF mice exhibited significant upregulation of hepatic fatty acid oxidation genes (particularly CPT1A), reflecting the characteristic gene expression patterns observed in clinical studies of TRF-induced improvement in hepatic steatosis (45, 46).